Our present results, which concur with pharmacological findings34–38, support the hypothesis that VSMC-EGFR is involved in VSMC responses to T2DM/obesity-associated stressors, because the effects were much stronger in WT VSMC compared to EGFR-KO VSMC. The gene discussed is EGFR; the disease is obesity due to melanocortin 4 receptor deficiency.